Pfizer

DSM and Codexis Sign Enzyme Supply Agreement

Ian C. Read to Replace Jeffrey Kindler at Pfizer

Pfizer CFO Eyeing Emerging Market Deals

Sanofi's Best Bet Still May Be Smaller Deals

Sanofi Investors Oppose Big Hike In Genzyme Bid

Sanofi Shareholders Want Genzyme For About $19 Billion

White Knight Could Be Elusive For Genzyme

U.S. Top Court Rejects Pfizer Nigeria Lawsuit Appeal

Big Pharma Stocks Could Rally in the Next Year

Pfizer Selling China Swine Vaccine Unit to Harbin Pharma

Pfizer Exec Jumps Ship to Head AstraZeneca's R&D

Sanofi to Invest in Japanese Generic Drug Maker

Pfizer Profit Beats, Forecast Unhurt by Reform

Codexis Prices at Bottom of Range

Bayer Still Out To Buy, Not Sell, Vet Businesses

Pfizer, Glaxo Sign 10-year Vaccine Deal for Poor

Pfizer Faces Hefty Price To Secure Stada

Nanotech Robots Deliver Gene Therapy Through Blood

Pfizer Expects EU Lipitor Extension Approval In May

Generic Deals May Still Hold Appeal for Pfizer

Teva to Buy Ratiopharm for Over $4.8 Billion

Three-way Ratiopharm Auction Comes To Head

Tekmira, Pfizer to Collaborate on RNAi Delivery System

Pfizer to Make Bid For Ratiopharm

China Drug List Seen Boosting Western Firms' Sales

Heir Merckle in Tussle with Banks Over Phoenix

Actavis Plays IPO Card In Ratiopharm Battle

Pfizer Woos Ratiopharm with Ramp-up Pledge

Up In The Air

Pfizer to Outline Ratiopharm Offer this Week

Actavis to Vie With Teva for Ratiopharm

What Would Ratiopharm Offer to a New Owner?

Ratiopharm Fields Decisive Takeover Bids

Top-Feature

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Predictive Simulation in Pharma Production

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Expert Insights

ADCs for Precision Cancer Therapy

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.